Good Bug raises Rs 29 crore in series A funding

Published On 2023-09-19 10:00 GMT   |   Update On 2023-09-19 11:12 GMT

Mumbai: The Good Bug - India's gut health focused brand, has announced that it has raised $3.5M in series A funding led by Fireside Ventures. The Company, founded by Keshav Biyani & Prabhu Karthikeyan, will deploy large part of the funds for new product development, team expansion and brand investments.

The brand addresses chronic issues across bloating, constipation, weight management others through the gut.
Commenting on this milestone, Keshav Biyani and Prabhu Karthikeyan, Founders of The Good Bug said," We aim to pioneer and expand the Gut Health category in India, which has been an unexplored segment. We’re unraveling the same by helping people get to the root cause of core health issues and holistically solve it. Our journey has been about more than just business; it's about transforming lives. We are thrilled to see the impact we've had on people's health and well-being. We are excited to have Fireside Ventures as our partner in this journey, with their deep knowledge of the Indian consumer & start-up eco-system.”
Advertisement
On the fundraise, Ankur Khaitan, Principal Fireside Ventures, said, "As consumers are getting more health-conscious and looking for safe and effective solutions with long term benefits; we see a huge potential for gut health. The Good Bug is at the forefront of this segment with their innovative and effective products. We are thrilled to partner with the team as they continue to pursue their vision.”

Read also: MediBuddy secures Rs 148 crore funding to drive strategic acquisitions, continued expansion



Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News